Lumexa Imaging Quarterly Income Statement
NASDAQ: LMRIHealth CareMedical SpecialitiesUSD
10.54+0.21 (+2.03%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lumexa Imaging revenue and earnings
In the quarter ended Jun 30, 2026, Lumexa Imaging generated $264.2 million in revenue. Net income was $2.7 million, for a net margin of 1.0% versus a median of -2.9% in the prior 3 quarters. Operating margin was 8.7%.
Diluted earnings per share came in at $0.03.
Summary generated from market data by MetaCap's automated system. Methodology
Lumexa Imaging income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Revenue | 264.16M | 252.54M | 251.40M | 245.00M |
| Revenue growth (YoY) | — | — | — | — |
| Operating Expenses | 259.74M | 248.15M | 240.25M | 234.78M |
| Operating Income | 23.04M | 19.41M | 27.68M | 25.54M |
| Interest Expense | 16.22M | 16.33M | 30.10M | 29.85M |
| Other Income (Expense) | -17.27M | — | -30.10M | — |
| Pretax Income | 5.76M | 3.08M | -2.42M | -4.31M |
| Income Tax | 3.02M | 1.36M | 4.81M | 3.38M |
| Net Income | 2.75M | 1.72M | -7.23M | -7.69M |
| Net Income growth (YoY) | — | — | — | — |
| EPS (Basic) | 0.03 | 0.02 | -0.10 | -0.11 |
| EPS (Diluted) | 0.03 | 0.02 | -0.10 | -0.11 |
| Shares Outstanding (Basic) | 95.98M | 95.98M | 69.53M | 69.52M |
| Shares Outstanding (Diluted) | 96.04M | 95.98M | 69.53M | 69.52M |
| EBITDA | 33.12M | 29.33M | 36.96M | 34.59M |
| Operating Margin | 8.72% | 7.69% | 11.01% | 10.42% |
| Net Margin | 104.00% | 68.00% | -2.87% | -3.14% |
This table shows 4 quarterly periods of Lumexa Imaging's income statement, from Q2 2026 back to Q? 2025, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow LMRI's reporting calendar. What is a income statement?